Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic
Potosky, Arnold L.
Haddad, Bassem R.
Richards, Ernest W.
Christenson, Robert H.
Atkins, Michael B.
JournalJournal of Oncology
MetadataShow full item record
AbstractBackground: Patients with cancer and health care workers (HCW) are at higher risk for SARS-CoV-2 infection. There are limited data regarding the rate of symptomatic versus asymptomatic infection and subsequent seropositivity in both populations. Methods: We performed a prospective study of patients and HCW across two institutions during the first wave of the pandemic to analyze the prevalence of SARS-CoV-2 antibodies, the extent of associated symptoms, and durability of serologic response. Results: In 1,953 persons (733 patients and 1,220 HCW), overall seropositivity rates for 3.1% patients (95% CI 2.0-4.7) and 3.7% HCW (95% CI 2.7-4.9, p=0.520), were similar. Each institutions' seropositivity rates were numerically higher in HCW than patients. Non-Hispanic Whites and Asians had lower antibody rates (2.8%, 95% CI 2.0-3.8 and 3.3%, 95% CI 1.2-7.0) compared to Hispanics (6.9%, 95% CI 3.4-12.4) and non-Hispanic Blacks (5.9%, 95% CI 3.3-9.7), p < 0.001. Among persons with a positive SARS-CoV-2 antibody, 87% of patients and 56% of HCW did not recall having had a fever. Among HCW, administrative and technical personnel were most likely to be seropositive. The rate of persistent seropositivity at 3 months was similar between patients and HCW and was not influenced by the reporting of fever, cancer type, or therapy. Conclusion: These data suggest that patients are not at higher risk for febrile SARS-CoV-2 infections or more transient immunity than HCWs. Furthermore, racial differences and lack of association with the extent of HCW contact with COVID-19 patients suggest that community rather than hospital virus exposure was a source of many infections.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18143
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
- Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.
- Authors: Szajek K, Fleisch F, Hutter S, Risch M, Bechmann T, Luyckx VA, Güsewell S, Hirzel C, Cusini A, Group AS, AMICO Study Group.
- Issue date: 2022 Jan 10
- SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
- Authors: Trieu MC, Bansal A, Madsen A, Zhou F, Sævik M, Vahokoski J, Brokstad KA, Krammer F, Tøndel C, Mohn KGI, Blomberg B, Langeland N, Cox RJ, Bergen COVID-19 Research Group .
- Issue date: 2021 Feb 24
- Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.
- Authors: Allen N, Brady M, Ni Riain U, Conlon N, Domegan L, Carrion Martin AI, Walsh C, Doherty L, Higgins E, Kerr C, Bergin C, Fleming C
- Issue date: 2021
- kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers.
- Authors: Varona JF, Madurga R, Peñalver F, Abarca E, Almirall C, Cruz M, Ramos E, Castellano-Vazquez JM
- Issue date: 2021 Jul
- Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
- Authors: van Dam P, Huizing M, Roelant E, Hotterbeekx A, De Winter FHR, Kumar-Singh S, Moons P, Amajoud Z, Vulsteke C, Croes L, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M
- Issue date: 2021 May